Nanomedicine: An iron age for cancer therapy

Nature Nanotechnology

Volumn 11, Issue 11, 2016, Pages 921-922

  Tarangelo, Amy ^a   Dixon, Scott J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

CANCER THERAPY; IRON AGE;

MEDICAL NANOTECHNOLOGY;

CASPASE; FERUMOXYTOL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TRANSFERRIN; IRON;

CANCER CELL; CANCER THERAPY; CATALYSIS; CELL DEATH; CELL PROLIFERATION; HUMAN; IRON AGE; PRIORITY JOURNAL; SHORT SURVEY; NANOMEDICINE; NEOPLASM;

HUMANS; IRON; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; NUTRIENTS;

EID: 84988731050     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2016.199     Document Type: Short Survey

References (8)

1. Torti S. V. & Torti F. M. Nat. Rev. Cancer 13 342-355 (2013).
2. Trachootham D. Alexandre J. & Huang P. Nat. Rev. Drug Discov. 8 579-591 (2009).
3. Kim S. E. et al. Nat. Nanotech. 11 977-985 (2016).
4. Z anganeh S. et al. Nat. Nanotech. 11 986-994 (2016).
5. Dixon S. J. et al. Cell 149 1060-1072 (2012).
6. Gao M. et al. Mol. Cell 59 298-308 (2015).
7. Qian B. Z. & Pollard J. W. Cell 141 39-51 (2010).
8. Sarosiek K. A. et al. Mol. Cell 51 751-765 (2013).